INTRODUCTION
============

Homologous recombination (HR) facilitates genome duplication under replication stress by repairing DNA strand breaks or single-strand DNA (ssDNA) gaps and restarting stalled replication forks ([@B1]; [@B23]; [@B8]). During these processes, the strand exchange protein Rad51 coats ssDNA and enables ssDNA pairing with a homologous sequence to template new DNA synthesis. This leads to the formation of HR intermediates, such as D-loop and Holliday junction structures. A number of other proteins also play important roles in HR intermediate metabolism under these situations. In *Saccharomyces cerevisiae*, these include factors that promote HR intermediate formation or maintenance, such as the DNA helicase Mph1 and the Rad51 paralogue Shu complex ([@B27], [@B28]; [@B13]; [@B14]), and those that promote intermediate dissolution and resolution. The main dissolution factor is the STR complex, composed of the Sgs1 helicase, the topoisomerase Top3, and its partner, Rmi1 ([@B24]; [@B11]; [@B10]; [@B20]). In addition, the octameric Smc5/6 complex, composed of Smc5, Smc6, and six other subunits (Nse1, Mms21, and Nse3--6; [@B40]; [@B21]), also contributes to HR intermediate processing. The Smc5/6 complex is essential in budding yeast; like STR deletion mutants, its hypomorphic alleles show increased levels of HR intermediates that can be visualized as X-shaped structures (X-mols) on two-dimensional gel electrophoresis (2D gel; [@B40]; [@B9]; [@B13]; [@B35]; [@B6]; [@B12]).

Although the aforementioned proteins have been primarily studied in the recombination context, they also affect other aspects of the replication stress response, particularly the DNA damage checkpoint. DNA structures generated during perturbed replication can be bound by checkpoint sensor proteins, such as the Rad17-Mec3-Ddc1 complex, referred to as 9-1-1 based on its homologues (RAD9-HUS1-RAD1). The 9-1-1 complex and other sensor proteins recruit and activate the apical checkpoint kinase Mec1 in budding yeast ([@B31]; [@B8]). Activated Mec1 in turn phosphorylates and activates the main effector kinase, Rad53. Further phosphorylation of a large number of substrates by Mec1 and Rad53 leads to changes promoting replication stress tolerance, such as replication fork stabilization, activation of DNA repair processes, and delayed cell cycle progression ([@B31]; [@B8]). Links between the DNA damage checkpoint and HR have been documented. Of most relevance is that proteins involved both in recombination intermediate formation and dissolution (or resolution) influence the DNA damage checkpoint but in an opposite manner. In budding yeast, *sgs1∆* cells are defective in Rad53 activation ([@B18]; [@B24]; [@B28]), and in fission yeast, an *smc6* mutant fails to maintain the DNA damage checkpoint ([@B19]). In contrast, the lack of upstream HR factors, such as Rad51 and Shu, results in increased Rad53 activation, presumably due to increased ssDNA levels ([@B22]; [@B27], [@B28]).

Because the foregoing mutants simultaneously affect HR and checkpoint, deconvoluting the mechanism underlying their genetic interactions is difficult. For example, removing Rad51 and the Shu complex improves the tolerance of *smc6* and *sgs1∆* cells to replication stress ([@B34]; [@B27]; [@B4]; [@B13]; [@B14]). This suppression could be interpreted as *rad51*∆ or *shu*∆ reducing levels of recombination intermediates or X-mols ([@B27]; [@B13]; [@B14]). This interpretation would imply that X-mol accumulation is more toxic than the failure to initiate HR. However, because *rad51*∆ or *shu*∆ also increases the checkpoint response, the observed suppression could also be attributed to enhanced DNA damage checkpoint signaling. Thus far, it has been difficult to elucidate how recombination and DNA damage checkpoint separately affect the replication stress tolerance of *smc6* and *sgs1* mutants. Lack of this information prevents clear interpretation of the genetic observations and impedes our understanding of the physiological consequences of X-mol accumulation.

To address these issues, we examined a mutant allele of budding yeast Smc6, *smc6-P4*, which contains the K239R mutation. We previously showed that *smc6-P4* cells are extremely sensitive to replication stress and display an elevated level of X-mols when replicating in the presence of methyl methanesulfonate (MMS; [@B13]). Both defects are suppressed by the removal of Mph1, Shu, or the proliferating cell nuclear antigen--polyubiquitinating enzyme Mms2, with *mph1∆* having the strongest effect ([@B13]; [@B14]). Here we show that *smc6-P4* and *mph1∆* exert opposite effects on the DNA damage checkpoint: *mph1∆* increases it, whereas *smc6-P4* decreases it, and the *smc6-P4 mph1∆* double mutant behaves like *mph1∆*. To assess the contribution of increased checkpoint response to the replication stress tolerance of *smc6-P4*, we used two strategies that alter the checkpoint circuitry to enhance the DNA damage checkpoint. Both corrected Rad53 phosphorylation defects in *smc6-P4* cells without reducing X-mol levels. They also increased *smc6-P4* tolerance to transient, but not chronic, replication stress, whereas *mph1∆* conferred tolerance to both. Furthermore, we reduced the checkpoint response in *smc6-P4 mph1∆* double mutants by removing the checkpoint sensor protein Mec3 and found that *mph1∆* can still suppress the sensitivity of *smc6-P4* cells to chronic replication stress. These results suggest that, whereas enhanced DNA damage checkpoint promotes tolerance to transient replication stress, X-mol removal is required for the survival of *smc6* mutants under persistent exposure to such stress.

RESULTS
=======

*smc6* and *mph1* mutations have opposite effects on the DNA damage checkpoint
------------------------------------------------------------------------------

The *mph1∆* mutation strongly suppresses a number of *smc6-*mutant defects, notably conferring three orders of magnitude more resistance to the replication-blocking agent MMS ([@B13]). Although our previously reported decrease in X-mol levels might be one cause ([@B13]) of the strong suppression, additional mechanisms might also contribute. Because HR mutants influence the DNA damage checkpoint response, we examined whether *mph1∆* and *smc6-P4* also alter this important replication stress tolerance mechanism and, if so, how this is related to the observed suppression.

We first examined how *mph1∆* and *smc6-P4* affect Rad53 phosphorylation, a standard readout of the activation of Rad53 and DNA damage checkpoint. Rad53 phosphorylation is indicated by the appearance of a higher--molecular weight band on immunoblots and can be seen in wild-type cells after 0.03% MMS treatment ([Figure 1A](#F1){ref-type="fig"}). After the same treatment, *mph1∆* resulted in a complete upward shift of Rad53, a characteristic feature of Rad53 hyperphosphorylation ([Figure 1A](#F1){ref-type="fig"}). In contrast, *smc6-P4* cells exhibited less Rad53 phosphorylation, as the phosphorylated Rad53 band (Rad53-P) is weaker in intensity than that of wild-type cells ([Figure 1A](#F1){ref-type="fig"}). *smc6-P4 mph1∆* double mutants behaved similarly to *mph1∆*, indicating that *mph1∆* results in Rad53 hyperphosphorylation in both wild-type and *smc6-P4* cells.

![Examination of Rad53 phosphorylation and bulk replication in cells defective in Mph1 and Smc6. (A) *mph1* and *smc6* mutations differentially affect Rad53 activation. Exponentially growing asynchronous cultures were treated with 0.03% MMS for 2 h. Rad53 phosphorylation was examined in cells before (--) and after (+) MMS treatment by Western blot. The levels of Rad53 phosphorylation were decreased in *smc6-P4* but increased in *mph1∆*, *mph1-hd*, *smc6-P4 mph1∆*, and *smc6-P4 mph1-hd* cells. Bottom, amido black stain of the gel. The bands representing unmodified and phosphorylated Rad53 are labeled as Rad53 and Rad53-P, respectively. (B--D) Examination of the kinetics of Rad53 phosphorylation in *mph1Δ*, *smc6-P4*, and *mph1∆ smc6-P4* cells. (B) Schematic of the experimental procedure. G1-synchronized cells were released into media containing 0.03% MMS. Cells were withdrawn at the indicated time points to monitor Rad53 phosphorylation by Western blot and DNA contents by FACS. (C) On treatment with MMS, *smc6-P4* cells show reduced Rad53 phosphorylation, whereas *mph1∆* and *smc6-P4 mph1∆* cells exhibit persistent Rad53 phosphorylation. (D) *mph1*∆ and *mph1∆ smc6-P4* cells display slower S-phase progression in MMS-containing media than WT and *smc6-P4* cells. FACS analysis of samples from C are shown with those of asynchronous cultures (asyn).](2431fig1){#F1}

To determine whether the altered Rad53 phosphorylation levels in *smc6* and *mph1* mutants reflect a change in the initial activation or maintenance of Rad53 modification, we performed time course experiments in which G1-synchronized cells were released into MMS-containing media ([Figure 1B](#F1){ref-type="fig"}). In wild-type cells, the Rad53-P band appeared at 20 min postrelease, peaked at 40 min, and diminished at 180 min, when most cells had finished replication, as judged by flow cytometry (fluorescence-activated cell sorting \[FACS\]; [Figure 1, C](#F1){ref-type="fig"} and [D](#F1){ref-type="fig"}). In *smc6-P4* cells, Rad53-P band was also visible 20 min postrelease, but the magnitude of phosphorylation did not reach the maximum level seen in wild-type (WT) cells ([Figure 1C](#F1){ref-type="fig"}). This difference between the two strains could not be caused by cell-cycle progression changes, since their FACS profiles were similar ([Figure 1D](#F1){ref-type="fig"}). We conclude that *smc6-P4* cells are defective in maximal Rad53 phosphorylation and, by extension, its activation.

In *mph1*∆ cells, Rad53 phosphorylation appeared to be stronger than wild type at 20 min and reached the maximum level at 40 min postrelease. Of importance, *mph1∆* cells failed to attenuate Rad53 phosphorylation even at 180 min ([Figure 1C](#F1){ref-type="fig"}). Consistent with persistent Rad53 phosphorylation, *mph1∆* cells also exhibited a delay in S-phase progression compared with wild-type cells ([Figure 1, C and D](#F1){ref-type="fig"}). *mph1∆ smc6-P4* cells behaved similarly to *mph1∆* cells in terms of Rad53 phosphorylation level and S-phase progression ([Figure 1, C and D](#F1){ref-type="fig"}). Therefore data from both asynchronous and time course experiments show that *smc6-P4* and *mph1∆* have opposite effects on Rad53 phosphorylation and that *mph1*∆ is epistatic to *smc6-P4* for this phenotype.

Because mutations of key residues in the Mph1 helicase domain (*mph1-hd*) that abolish its helicase activity suppress *smc6-P4*'s MMS sensitivity and X-mol accumulation similarly to *mph1∆* ([@B13]), we asked whether *mph1-hd* also affects the DNA damage checkpoint. We found that *mph1-hd* behavior resembled that of *mph1*∆ in both asynchronous and synchronized experiments. *mph1-hd* cells showed Rad53 hyperphosphorylation and slower S-phase progression, regardless of Smc6 status ([Figure 1A](#F1){ref-type="fig"} and Supplemental Figure S1). Thus the lack of Mph1 helicase activity accounts for the observed effects on the DNA damage checkpoint. These results raise the possibility that the mounting of a more robust DNA damage checkpoint response is partly responsible for *mph1* suppression of *smc6-P4* MMS sensitivity. This effect could serve to stabilize stalled replication forks and provide more time for repairing DNA lesions.

Mec1 is required for the persistence of Rad53 phosphorylation and slow S-phase progression in *mph1*∆ mutants
-------------------------------------------------------------------------------------------------------------

In budding yeast, Mec1 is the main checkpoint kinase that controls Rad53 activation and S-phase progression, and its homologue, Tel1, makes minor contributions ([@B31]; [@B8]). To assess whether the observed *mph1* effect on the DNA damage checkpoint is due to a change in the Mec1-dependent pathway, we examined *mec1∆* cells containing *sml1∆*, a suppressor of *mec1∆* lethality that does not affect checkpoint function ([@B42]). As shown in [Figure 2A](#F2){ref-type="fig"} and consistent with the literature, *mec1∆* cells contain unphosphorylated Rad53 and progress through S phase more rapidly than wild-type cells after MMS treatment. The removal of Mec1 in *mph1∆* or *mph1∆ smc6-P4* cells largely abolished Rad53 phosphorylation and the observed S-phase delay ([Figures 2, A and B](#F2){ref-type="fig"}). We conclude that the increased Rad53 phosphorylation and delayed replication seen in both *mph1∆* and *mph1∆ smc6-P4* cells are dependent on Mec1-mediated checkpoint activities. Delayed replication in wild-type cells under genotoxic stress is due to Mec1-mediated inhibition of late replication origin firing ([@B32]; [@B33]). Thus this is more likely accountable for the S-phase delay in *mph1* mutants than an inability to repair damaged DNA.

![Mec1-mediated Rad53 hyperphosphorylation and slower DNA synthesis in cells containing *mph1∆*. (A) *mec1∆* abolishes Rad53 hyperphosphorylation in *mph1∆* and *mph1∆ smc6-P4* cells. Rad53 phosphorylation was analyzed in asynchronous cells as described in [Figure 1A](#F1){ref-type="fig"}. (B) *mec1∆* reverts the slow S-phase progression in *mph1∆* and *mph1∆ smc6-P4* cells. Cells were synchronized and released as in [Figure 1B](#F1){ref-type="fig"}, and DNA content was monitored by FACS. All *mec1∆* cells contain the lethality suppressor *sml1∆*.](2431fig2){#F2}

*TEL1-hy909* promotes the survival of *smc6-P4* cells upon transient, but not chronic, replication stress
---------------------------------------------------------------------------------------------------------

Because *smc6-P4 mph1*∆ cells exhibit higher Rad53 phosphorylation levels than *smc6-P4* cells, we asked whether enhancing the DNA damage checkpoint alone could improve the replication stress tolerance of *smc6-P4* cells. To this end, we used two different approaches that directly alter checkpoint circuitry. The first approach used the *TEL1-hy909* gain-of-function allele, which results in elevated Tel1 kinase activity and Rad53 hyperphosphorylation ([@B3]). We confirmed Rad53 hyperphosphorylation in *TEL1-hy909* cells after MMS treatment in a time course experiment (Supplemental Figure S2A). The degree of Rad53 hyperphosphorylation caused by *TEL1-hy909* is similar to that seen with *mph1∆*, although only the latter slows S-phase progression (Supplemental Figure S2A). As reported previously, *TEL1-hy909* greatly improved the survival of *mec1∆* cells during chronic exposure to MMS (Supplemental Figure S2A; [@B3]). These results together indicate that *TEL1-hy909* augments a critical aspect of the Mec1-mediated checkpoint response to increase viability in MMS-containing media. That *TEL1-hy909* did not significantly affect late replication origin firing as reflected by FACS analysis is consistent with the notion that this aspect of checkpoint control is not essential for cell survival upon replication stress ([@B37]).

After confirming that *TEL1-hy909* can hyperactivate checkpoint under our experimental conditions, we examined its effect on the checkpoint response, recombination intermediate levels, and MMS sensitivity of *smc6-P4* cells in a time course experiment. First, we found that *TEL1-hy909* increased the level of Rad53 phosphorylation in *smc6-P4* cells, albeit less strongly than *mph1∆* ([Figure 3A](#F3){ref-type="fig"}). *TEL1-hy909* did not affect S-phase progression as seen in wild-type cells ([Figure 3A](#F3){ref-type="fig"}). Consistent with its observed Rad53 hyperphosphorylation and like *mph1∆*, *TEL1-hy909* resulted in a greater degree of degradation of the ribonucleotide reductase inhibitor Sml1, another frequently used readout of DNA damage checkpoint function ([Figure 3A](#F3){ref-type="fig"} and Supplemental Figure S3A; [@B41]). Second, *TEL1-hy909* did not reduce X-mol levels in *smc6-P4* cells throughout the time course, suggesting that increased checkpoint response does not grossly decrease HR intermediate levels ([Figure 3B](#F3){ref-type="fig"}). Third, *TEL1-hy909* improved the viability of *smc6-P4* cells to a similar degree as *mph1∆* when cells were withdrawn at each time point to assess survival ([Figure 3C](#F3){ref-type="fig"}). Thus hyperactivation of the DNA damage checkpoint alone without reducing X-mol levels is sufficient for improving the tolerance of *smc6-P4* cells to transient replication stress.

![The effects of *TEL1-hy909* on the DNA damage checkpoint and MMS sensitivity of *smc6-P4* cells. (A) *TEL1-hy909* increases Rad53 phosphorylation and Sml1 degradation in *smc6-P4* cells. Experiments were carried out as described in [Figure 1B](#F1){ref-type="fig"}. *TEL1-hy909* increases Rad53 phosphorylation in *smc6-P4* as shown by Western blot (left) and quantification (right). The level of Sml1 protein was examined (middle) and quantified using tubulin as a loading control in Supplemental Figure S3A. FACS analysis for each strain is shown below the blot. (B) *TEL1-hy909* does not affect X-mol levels in *smc6-P4* cells. Cells were treated as in A. Recombination intermediates, that is, X-mols (arrowheads) at the ARS305 region were analyzed by 2D gel electrophoresis at indicated time points. Right, FACS profiles. Bottom, quantification of X-mol levels. (C) *TEL1-hy909* improves survival of *smc6-P4* cells after transient exposure to MMS. Experiments were carried out as in A. Cells of indicated genotypes were plated out to determine the survival percentage of colonies at indicated time points. Each time point represents the mean of two independent experiments, and the SD is given. *p* value denotes that the difference in the viability of *smc6-P4* and *smc6-P4 TEL1-hy909* cells is statistically significant. (D) *TEL1-hy909*, unlike *mph1∆*, does not suppress the sensitivity of *smc6-P4* to chronic exposure to MMS.](2431fig3){#F3}

Next we examined how *TEL1-hy909* affects *smc6-P4* cell survival during chronic MMS exposure. We found that, unlike *mph1*∆, *TEL1-hy909* did not improve the viability of *smc6-P4* cells during chronic exposure to MMS, even at a concentration lower than the one at which it suppresses the lethality of *mec1∆* ([Figure 3D](#F3){ref-type="fig"}). Taken together, the results indicate that increasing Rad53 phosphorylation levels by *TEL1-hy909* promotes the survival of *smc6-P4* cells after transient but not chronic exposure to MMS.

*TEL1-hy909* improves chromosomal replication and segregation of *smc6-P4* cells
--------------------------------------------------------------------------------

To understand how DNA damage checkpoint hyperactivation improves *smc6-P4* tolerance to transient replication stress, we examined both chromosomal replication and segregation. Because *smc6-P4* cells began to lose viability in S phase when treated with MMS, we first examined chromosomal replication using pulsed-field gel electrophoresis (PFGE). We treated G1 cells with a pulse of MMS and then released them into the cell cycle in normal media ([Figure 4A](#F4){ref-type="fig"}). Based on the criterion that only fully replicated chromosomes can enter the gel, wild-type cells appeared to complete replication at around 60 min ([Figure 4, A--C](#F4){ref-type="fig"}). In contrast, *smc6-P4* cells failed to finish chromosomal replication even at 240 min postrelease. Introduction of *TEL1-hy909* increased extent of replication completion in *smc6-P4* cells ([Figure 4, A--C](#F4){ref-type="fig"}). These results suggest that enhanced checkpoint response can improve replication capacity in *smc6-P4* cells after transient MMS treatment.

![*TEL1-hy909* improves chromosome replication and segregation in *smc6-P4* cells. (A--C) Pulsed field gel electrophoresis analysis of cells with the indicated genotype during the course of recovery from transient MMS treatment (A). (A, top) Experimental scheme. (B) FACS analysis of the examples. (C) Quantification of representative chromosomal bands. The relative intensity of the chromosomal bands in *smc6-P4* and *smc6-P4 TEL1-hy909* at 180 and 240 min postrelease are statistically different (*p* \< 0.05, Student\'s *t* test). Standard deviations for each time point are depicted. (D) Examination of nuclear segregation. Cells were treated as in A--C and microscopically examined at 240 min postrelease. Left, representative pictures of each category of cells, with Tub1-GFP marking the spindle and Hoechst staining of the nucleus. Cells were categorized as previously described ([@B36]). Briefly, G1/S cells have no or small buds with single nucleus and short spindle in the mother cells; G2/M cells have medium to large buds with single nucleus close to the bud neck and a short spindle; anaphase cells have large buds with nucleus spanning between two cells and medium-length spindle; telophase cells have large buds with separated nuclei and elongated spindle; large-budded cells with nucleus away from the bud neck were categorized as nuclear mispositioning or missegregation. Two independent spores were examined for each genotype, and cell number (*n*) is indicated. The average percentage of each category of cells is shown. Statistically significant differences between WT and *smc-6-P4* and between *smc6-P4* and *smc6-P4 TEL1-hy909* are denoted below *smc6-P4* and *smc6-P4 TEL1-hy909*, respectively.](2431fig4){#F4}

We also assessed chromosome segregation at 240 min postrelease in the foregoing experiment. Compared with wild type, *smc6-P4* strains exhibited fewer normal anaphase and telophase cells but more large-budded cells with missegregated or mispositioned nuclei (*p* \< 0.05; [Figure 4, D and E](#F4){ref-type="fig"}). *TEL1-hy909* increased the former populations and decreased the latter (*p* \< 0.05; [Figure 4, D and E](#F4){ref-type="fig"}). One interpretation is that correction of checkpoint defect in *smc6-P4* cells by *TEL1-hy909* is sufficient to improve chromosome segregation, leading to better survival.

Induced proximity of Ddc1 and Ddc2 enhances DNA damage checkpoint response and improves survival of *smc6-P4* cells upon transient exposure to MMS
--------------------------------------------------------------------------------------------------------------------------------------------------

We also used another strategy to increase checkpoint response, on the basis of the observation that induced proximity of the DNA damage checkpoint sensor protein Ddc1 and the Mec1 binding partner Ddc2 is sufficient to activate checkpoint ([@B7]). In this system, Ddc1 and Ddc2 are fused to LacI--green fluorescent protein (GFP) modules, and their targeting to chromosomal LacO arrays results in Rad53 phosphorylation and checkpoint activation even without DNA damage in S and G2/M phases. This likely occurs via Mec1-Ddc2 recruitment to chromatin by the 9-1-1 complex ([@B7]). We tested how this system affects DNA damage checkpoint responses, X-mol levels, and replication stress tolerance in *smc6-P4* cells.

The expression of Ddc1 and Ddc2 fusion constructs was induced by a pulse of galactose in G1-arrested cells before the cells were released into MMS-containing glucose media. Because this system activates Rad53 even without DNA-damaging agents, we used a lower concentration of MMS (0.005%). Time course experiments show that this induction led to Rad53 hyperphosphorylation in both WT and *smc6-P4* backgrounds ([Figure 5A](#F5){ref-type="fig"}; compare the lanes with and without expression of the constructs). This effect on Rad53 phosphorylation is similar to that induced by *mph1∆* ([Figure 5A](#F5){ref-type="fig"}). Consistent with this, lower levels of the Sml1 protein were detected when Ddc1 and Ddc2 fusions were induced in both WT and *smc6-P4* cells ([Figure 5A](#F5){ref-type="fig"} and Supplemental Figure S3B). Examination of replication intermediates by 2D gel found that the engineered Ddc1-Ddc2 juxtaposition did not alter X-mol levels in *smc6-P4* cells ([Figure 5B](#F5){ref-type="fig"}). Finally, this system was as effective as *mph1∆* in improving *smc6-P4* survival after transient exposure to MMS ([Figure 5B](#F5){ref-type="fig"}). These results are consistent with those obtained for *TEL1-hy909;* taken together, they strongly suggest that increasing Rad53 activation in *smc6-P4* cells is sufficient for increasing their resistance to transient replication stress. Because prolonged expression of the Ddc1 and Ddc2 fusions can impair replication ([@B7]), this system cannot be used to evaluate responses to chronic MMS exposure.

![Juxtaposition of Ddc1 and Ddc2 increases DNA damage checkpoint response and improves tolerance to acute treatment of MMS in *smc6-P4* cells. (A) Induction of the Ddc1 and Ddc2 fusion constructs (Ddc1-Ddc2) increases Rad53 phosphorylation and Sml1 degradation in both wild-type and *smc6-P4* cells. G1-arrested cells were induced for the expression of this system and released into MMS-containing media. Protein samples and DNA content were examined as in [Figure 3A](#F3){ref-type="fig"}. (B, C) Induction of the Ddc1 and Ddc2 juxtaposition does not reduce X-mol levels but improves *smc6-P4* cell survival upon transient exposure to MMS. The 2D gel analysis of X-mols (arrowheads, B) and viability test (C) were performed as in [Figure 3](#F3){ref-type="fig"}. The *p* value denotes that the difference in the viability of indicated strains is statistically significant.](2431fig5){#F5}

Removal of DNA damage checkpoint sensor proteins Mec3 and Rad24 does not affect *smc6-P4 mph1∆* tolerance of chronic MMS treatment
----------------------------------------------------------------------------------------------------------------------------------

The results obtained so far suggest that correcting Rad53 phosphorylation in *smc6-P4* cells by *TEL1-hy909* or the juxtaposition of Ddc1 and Ddc2 can increase cellular tolerance to transient but not chronic MMS exposure. To determine directly whether *mph1∆*-mediated checkpoint hyperactivation contributes to the viability of *smc6-P4 mph1∆* cells upon chronic MMS treatment, we reduced the checkpoint response in this double mutant by removing the checkpoint sensor protein Mec3.

Unlike *mec1∆*, which exhibited strong synthetic sickness with *mph1∆* in the presence of MMS (Supplemental Figure S2C)*, mec3∆* did not appear to affect *mph1*∆ survival on MMS-containing media (Supplemental Figure S4). Thus it is possible to determine whether reducing checkpoint response via *mec3*∆ affects the suppression of *smc6-P4* cells by *mph1∆*. As shown in [Figure 6A](#F6){ref-type="fig"}, *mec3*∆ diminished Rad53 phosphorylation in *mph1*∆, *smc6-P4*, and *smc6-P4 mph1*∆ cells. Quantification showed that *mec3*∆ effectively reduced Rad53 phosphorylation levels in *smc6-P4 mph1*∆ cells such that the triple mutant displays a similar degree of Rad53 phosphorylation as *smc6-P4* cells ([Figure 6B](#F6){ref-type="fig"}). Of importance, *mec3∆* did not alter X-mol levels significantly in either *smc6-P4* or *smc6-P4 mph1∆* cells in time course experiments when G1 cells were released into MMS-containing media ([Figure 6C](#F6){ref-type="fig"}). Finally, we found that *mph1*∆ still conferred robust suppression of *smc6-P4* MMS sensitivity in the absence of Mec3 ([Figure 6D](#F6){ref-type="fig"}). A similar effect was also seen with removal of the Mec3 loader, Rad24 ([Figure 6D](#F6){ref-type="fig"} and Supplemental Figure S4). Taken together, these results suggest that improvement of *smc6-P4* survival of chronic MMS exposure by *mph1∆* is more a consequence of reduced X-mol levels than of enhanced checkpoint response.

![*mec3∆* reduces Rad53 phosphorylation without affecting X-mol levels or survival upon MMS treatment in *smc6-P4* and *smc6-P4 mph1∆* cells. (A, B) *mec3∆* decreases Rad53 phosphorylation upon MMS treatment. Cells were treated as in [Figure 1](#F1){ref-type="fig"}, and Rad53 phosphorylation is examined in A and quantified in B. The percentage of Rad53-P in *smc6-P4 mph1∆ mec3∆* is statistically different from that in *smc6-P4* and *smc6-P4 mph1∆* cells (*p* \< 0.05, Student\'s *t* test). (C) Removal of Mec3 does not affect X-mol levels in *smc6-P4* or *smc6-P4 mph1*∆ cells. Experiments were carried out as in [Figure 3B](#F3){ref-type="fig"}. (D) Neither *mec3∆* nor *rad24∆* affects *mph1∆* suppression of *smc6-P4* sensitivity upon chronic exposure to MMS. (E) A summary of the results and a model for the differential effects of checkpoint and recombination on *smc6* mutant tolerance to replication stress. More details are given in the *Discussion*.](2431fig6){#F6}

DISCUSSION
==========

Unraveling the genetic relationships between some recombinational repair proteins is complicated by their additional effects on the DNA damage checkpoint. We previously showed that removing the DNA helicase Mph1 or mutating its key enzymatic residues reduces X-mol levels and strongly suppresses the MMS sensitivity of *smc6-P4* cells ([@B13]). Our new data show that *smc6-P4* and *mph1∆* (or *mph1-hd*) have opposing effects on the Mec1 checkpoint. *smc6-P4* cells failed to phosphorylate Rad53 to wild-type levels upon MMS treatment, whereas *mph1∆* (or *mph1-hd*) exhibited persistent Rad53 phosphorylation ([Figure 1](#F1){ref-type="fig"} and Supplemental Figure S1). Although the underlying reason for these effects is not entirely clear, it likely pertains to alteration of ssDNA levels or replisome stability as suggested for similar situations (Cobb *et al.*, 2005, [@B19]; [@B2]; Yeung *et al.*, 2011). Besides Rad53 hyperphosphorylation, *mph1∆* (or *mph1-hd*) also resulted in a strong Mec1-dependent S-phase delay, and *smc6-P4 mph1∆* behaved like *mph1∆* ([Figure 2](#F2){ref-type="fig"}). These novel observations of DNA damage checkpoint effects raised the question of whether an enhanced checkpoint response is sufficient to improve *smc6-P4* survival upon replication stress.

To address this question, we used two different approaches to augment the DNA damage checkpoint response without affecting X-mol levels. Both the hyperactive *TEL1-hy909* allele and the induced proximity of Ddc1 and Ddc2 increased Rad53 phosphorylation levels in cells with normal and defective Smc6 upon MMS treatment, with a stronger effect seen in the latter ([Figures 3A](#F3){ref-type="fig"} and [5A](#F5){ref-type="fig"} and Supplemental Figure S2A). Both resulted in a greater degree of Sml1 degradation, consistent with an enhanced checkpoint response ([Figures 3A](#F3){ref-type="fig"} and [5A](#F5){ref-type="fig"} and Supplemental Figure S3). Neither *TEL1-hy909* nor the Ddc1-Ddc2 system lowered the level of X-mols in *smc6-P4* cells, suggesting that checkpoint hyperactivation does not affect HR intermediate levels and that these alleles can be used to isolate checkpoint- from HR-dependent effects ([Figures 3B](#F3){ref-type="fig"} and [5B](#F5){ref-type="fig"}). We found that both strategies improved the replication stress tolerance of *smc6-P4* cells during a time course of 2-h exposure to MMS ([Figures 3C](#F3){ref-type="fig"} and [5C](#F5){ref-type="fig"}). We note that *TEL1-hy909* also improved the checkpoint response and survival of another *smc6* mutant, *smc6-56*, after exposure to transient replication stress (Supplemental Figure S5, A and B). Thus improved *smc6* mutant resistance to acute replication stress can be achieved solely by DNA damage checkpoint hyperactivation. Our results further show that an enhanced checkpoint response can improve replication capacity and chromosomal segregation in *smc6-P4* cells ([Figure 4, A--D](#F4){ref-type="fig"}). This is presumably achieved by promoting replication fork stability and allowing more time for nuclear segregation. However, other effects, such as those involving previously reported effects on kinetochore and spindle functions ([@B39]), may also contribute.

Although *TEL1-hy909* suppressed *smc6-P4* sensitivity during transient MMS exposure to a similar extent as *mph1∆*, only *mph1*∆ promoted the survival of *smc6-P4* cells during chronic MMS treatment ([Figure 3D](#F3){ref-type="fig"}). This argues that the observed suppression by *mph1*∆ involves more than just checkpoint hyperactivation. This idea is further supported by the observation that *mph1*∆ still confers suppression to *smc6-P4* cells under chronic and transient MMS treatment upon *MEC3* deletion, which reduced the checkpoint response without affecting X-mol level ([Figure 6, A--D](#F6){ref-type="fig"}, and data not shown). Thus the observed *mph1* suppression is at least partly due to a reduction in recombination intermediate levels. We note that a recent study reports the ability of *mec3∆* to partially reduce X-mol levels in *sgs1∆* cells ([@B26]), whereas we detected no such effect in *smc6-P4* cells ([Figure 6C](#F6){ref-type="fig"}). This difference is consistent with previously noted differences in the effect of *mph1∆* on X-mol levels in *smc6-P4* versus *sgs1∆* cells ([@B13]; [@B28]), thus arguing for differential pathway involvement of the Smc5/6 complex versus Sgs1, in addition to their common functions.

On the basis of our results, we propose a two-phase model to explain the severe sensitivity of *smc6* mutant cells to replication stress ([Figure 6E](#F6){ref-type="fig"}). When replication forks are stalled due to transient stress, a strong DNA damage checkpoint response is advantageous to *smc6* mutants. On chronic exposure to replication stress, however, preventing HR intermediate accumulation becomes the dominant factor for mutant cell survival. In this model, the checkpoint-related and X-mol regulation functions of the Smc5/6 complex are separable. This model may also be applicable to other mutants, such as *sgs1*∆ and *esc2*∆, as they also exhibit X-mol accumulation and checkpoint defects and their MMS sensitivity is suppressed by the removal of recombination factors such as Rad51 and Shu ([@B24]; [@B28]; [@B35]; [@B14]). The tools used here to dissect the contributions of checkpoint hyperactivation and recombination may be useful for evaluating these cases as well. Our observation that neither hyperactivation nor reduction of checkpoint in *smc6-P4* cells affected HR intermediate levels suggests that checkpoint does not affect at least one branch of recombination-mediated damage bypass. This extends previous observations that checkpoint does not inhibit all modes of recombinational repair under replication stress, although it hinders those at chromosomal breaks, as measured by Rad52 foci levels ([@B25]; [@B2]; [@B5]). In addition, our findings may be related to those in higher eukaryotes, in which the regulation of HR products is important for prolonged but not transient exposure to replication stress ([@B30]). Compounded, these studies begin to unravel the complex interplay between checkpoint and recombinational repair. Further investigation into the underlying mechanisms of this interplay will provide insight into how these two important genotoxic tolerance mechanisms are coordinated at the molecular level.

MATERIALS AND METHODS
=====================

Yeast strains
-------------

The yeast strains used in this study are listed in [Table 1](#T1){ref-type="table"} and Supplemental Table 1. They are derivatives of W1588-4C, a *RAD5* derivative of W303 (*MAT***a** *ade2-1 can1-100 ura3-1 his3-11,15 leu2-3112 trp1-1 rad5-535*; [@B38]). Only one strain for each genotype is listed, but at least two independent spore clones of each genotype were used in each of the experiments. Standard yeast protocols were used for strain construction, growth, and medium preparation. The construction of *smc6-P4* and *smc6-56* strains was described previously ([@B13]).

###### 

Yeast strains used in this study.

  Name        Relevant genotype
  ----------- -------------------------------------------------------------------------------------------------------
  X3117-8B    *MAT*a *RAD53-3Flag::LEU2*
  X3117-16B   *MAT*a *RAD53-3Flag::LEU2 mph1∆::KAN*
  X3223-19A   *MAT*a *RAD53-3Flag::LEU2 smc6-P4-13Myc::HIS3*
  X3117-15A   *MAT*a *RAD53-3Flag::LEU2 smc6-P4-13Myc*::*HIS3 mph1∆::KAN*
  X3660-8C    *MAT*a *RAD53-3Flag::LEU2 mph1-Q603D::HIS3*
  X3660-5C    *MAT*a *RAD53-3Flag::LEU2 smc6-P4-13Myc*::*KAN mph1-Q603D ::HIS3*
  X3659-18D   *MAT*a *RAD53-3Flag::LEU2 mec1∆::TRP1 sml1*∆*::HIS3*
  X3659-14D   *MAT*a *RAD53-3Flag::LEU2 mec1∆::TRP1 sml1*∆*::HIS3 mph1∆::KAN*
  X3659-12C   *MAT*a *RAD53-3Flag::LEU2 mec1∆::TRP1 sml1*∆*::HIS3 smc6-P4-13Myc*::*KAN mph1∆::KAN*
  X3445-5A    *MAT*a *RAD53-3Flag::LEU2 smc6-P4-13myc::HIS3 TEL1-hy909 ::LEU2*
  X3845-7B    *MAT*a *RAD53-HA::LEU2 GalS-DDC1-GFP-LacI::URA3 Gal-DDC2-GFP-LacI::HIS3 ddc1∆ LacO::TRP1*
  X3845-11C   *MAT*a *smc6-P4-13myc::KAN RAD53-HA::LEU2 GalS-DDC1-GFPLacI::URA3 Gal-DDC2-GFP-LacI::HIS3 LacO::TRP1*
  X4186-5D    *MAT*a *RAD53-3Flag::LEU2 mec3∆::URA3*
  X4186-6D    *MAT*a *RAD53-3Flag::LEU2 mec3∆::URA3 mph1*∆*::KAN*
  X4186-18B   *MAT*a *RAD53-3Flag::LEU2 mec3∆::URA3 smc6-P4-13myc::HIS3*
  X4186-12C   *MAT*a *RAD53-3Flag::LEU2 mec3∆::URA3 smc6-P4-13myc::HIS3 mph1*∆*::KAN*
  X4187-6D    *MAT*a *RAD53-3Flag::LEU2 rad24∆::TRP1smc6-P4-13myc::HIS3 mph1*∆*::KAN*
  X3903-18D   *MAT*a *trp1::TUB1-GFP::TRP1*
  X3903-19C   *MAT*a *trp1::TUB1-GFP::TRP1 smc6-P4-13myc::HIS3*
  X3903-19D   *MAT*a *trp1::TUB1-GFP::TRP1 smc6-P4-13myc::HIS3 TEL1-hy909::LEU2*

Strains in this study are derivatives of W1588-4C, a *RAD5* derivative of W303 (*MAT*a *ade2-1 can1-100 ura3-1 his3-11,15 leu2-3112 trp1-1 rad5-535*). A single representative of each genotype is listed.

Cell synchrony and MMS treatment
--------------------------------

Cell synchronization was performed by adding α factor (Memorial Sloan-Kettering Cancer Center Proteomics Core) to cells growing in log phase to a final concentration of 5 μg/ml for ∼2 h and evaluating the percentage of unbudded cells in the culture. Galactose induction was carried out as previously described ([@B7]). In brief, cells were first arrested with α factor for 2 h, and then galactose was added for 2 h in the presence of α factor. The release from α factor was performed in the presence of MMS at a final concentration of 0.03 or 0.005% as indicated. Cell cycle progression was analyzed by FACS as performed previously ([@B43]). One representative result is presented for each genotype.

Survival assays
---------------

Spot assays for detecting DNA damage sensitivity were carried out as described previously ([@B13]). Briefly, log-phase cultures were serially diluted 10-fold and spotted onto agar plates containing yeast extract/peptone/dextrose media with the addition of the indicated doses of MMS. Plates were incubated at 30°C and photographed after at least 48 h. For killing curves, cultures challenged by MMS were taken at intervals, sonicated, and serially diluted before plating. An equal volume of 10% sodium thiosulfate was used to quench the effect of MMS in the sample before serial dilutions. The percentage of viable colonies was calculated by dividing the number of colonies by the number of cells plated based on the optical density readings of a spectrophotometer (Biomate 3; Thermo Scientific, Waltham, MA). Because the plating efficiency of each genotype varies in normal growth conditions, the viability of each genotype in MMS at each time point was determined by normalizing the percentage of the viable colonies to its plating efficiency. Unpaired Student\'s *t* test was used for statistical analysis.

Two-dimensional gel electrophoresis and protein detection
---------------------------------------------------------

The 2D gel electrophoresis was carried out and X-mols were quantified as described ([@B13]). To assay Rad53 phosphorylation and Sml1 protein levels, the trichloroacetic acid protein extraction method was used as originally described ([@B17]). The extracts were separated on standard SDS--PAGE gels and Western blotted, followed by probing with anti-Flag (Sigma-Aldrich, St. Louis, MO) or anti-hemagglutinin (Memorial Sloan-Kettering Cancer Center Monoclonal Antibody Core Facility) antibodies to detect Rad53, anti-Sml1 antibody to detect Sml1, and YL1/2 antibody (AbD Serotec, Raleigh, NC) to detect tubulin. The abundance of a protein was quantified by measuring the intensity of its band using Image Gauge (Fujifilm, Tokyo, Japan). The percentage of Rad53 phosphorylation was calculated using the signal of Rad53-P divided by total Rad53 signal. At least two independent spore clones per genotype were examined for each genotype, and the representative results are shown.

PFGE and microscopy analysis
----------------------------

Chromosome plugs were prepared and PFGE was performed as previously described ([@B16]). For microscopy, cells were fixed by addition of formaldehyde to a final concentration of 3.7% in the culture for 10 min, followed by washing with 0.1 M potassium phosphate, pH 8.1. Cells were then resuspended in a buffer of 1.2 M sorbitol and 0.1 M potassium phosphate, pH 8.1, and aliquots were stained with 4 μg/ml of Hoechst 33258 dye and processed for microscopy as previously described ([@B39]). The exposure times used for Tub1-GFP and Hoechst were 2 and 0.2 s respectively. All imaging was captured on an Axio Imager microscope (Carl Zeiss, Jena, Germany) with a 100× objective lens (numerical aperture 1.4). From 8 to 10 *Z*-sections with a 0.5-μm step size were taken to cover the whole yeast cell. Unpaired Student\'s *t* test was used for statistical analysis.
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FACS

:   fluorescence-activated cell sorting

HR

:   homologous recombination

MMS

:   methyl methanesulfonate

X-mol

:   X-shaped structure
